Calliditas Therapeutics AB - ADR (CALT) Live Stock Price, Forecast & News

Calliditas Therapeutics AB - ADR
CALT
(Nasdaq - US)
Closed
18.61
+0.96 (+5.44%)
in:usd•As of: Apr 19, 2024 15:13 UTC -4
Open
18.74
High
18.74
Low
17.68

Stats
Prev. Close
17.65
Open
18.74
Day's Range
17.68 - 18.74
52 Week Range
15.25 - 29.30
YTD Change
-27.71%
1 Year Change
-26.44%
Market Cap
554.39M
P/E Ratio
N/A
Volume
372.00
Beta
1.50
Sector
Health Technology
Industry
Pharmaceuticals Major
Economic CalendarAll Events
Time zone: GMT
Thursday, April 18th 2024
Time Currency Event Impact Actual Consensus Previous
14:00

USD
Existing Home SalesMar
Medium
4.19M 4.2M 4.38M
15:00

USD
Fed Bostic Speech
Medium
21:45

USD
Fed Bostic Speech
Medium
Friday, April 19th 2024
Time Currency Event Impact Actual Consensus Previous
14:30

USD
Fed Goolsbee Speech
Medium
Monday, April 22nd 2024
Time Currency Event Impact Actual Consensus Previous
12:30

USD
Chicago Fed National Activity IndexMar
Medium
0.09 0.05
Tuesday, April 23rd 2024
Time Currency Event Impact Actual Consensus Previous
13:45

USD
S&P Global Composite PMI FlashApr
Medium
52.2 52.1
13:45

USD
S&P Global Services PMI FlashApr
Medium
51.8 51.7
Latest News
Seeking AlphaFeb 21, 2024
Calliditas Therapeutics AB (publ) (CALT) Q4 2023 Earnings Call Transcript
CALT+5.44%
Market WatchDec 21, 2023
Calliditas Therapeutics stock jumps as kidney treatment gets FDA approval
CALT+5.44%
Seeking AlphaNov 27, 2023
Calliditas Therapeutics: Undervalued Rare Disease Commercial Stage Biotech (Maintaining Buy)
CALT+5.44%
Zacks Investment ResearchSep 22, 2023
Calliditas Therapeutics AB Sponsored ADR (CALT) Surges 16.1%: Is This an Indication of Further Gains?
CALT+5.44%
The Motley FoolSep 21, 2023
Why Shares of Calliditas Therapeutics Are Rising Thursday
CALT+5.44%
Seeking AlphaSep 3, 2023
Calliditas: Q2 Earnings De-Risk This Biotech Play, 2024 Expected To Be Inflection Point
CALT+5.44%
Read All
Data Vendor:
Stocks
Loading
Loading

Thursday, April 18th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
14:00	USD	Existing Home SalesMar	Medium	4.19M	4.2M	4.38M
15:00	USD	Fed Bostic Speech	Medium
21:45	USD	Fed Bostic Speech	Medium

Friday, April 19th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
14:30	USD	Fed Goolsbee Speech	Medium

Monday, April 22nd 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
12:30	USD	Chicago Fed National Activity IndexMar	Medium		0.09	0.05

Tuesday, April 23rd 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
13:45	USD	S&P Global Composite PMI FlashApr	Medium		52.2	52.1
13:45	USD	S&P Global Services PMI FlashApr	Medium		51.8	51.7

Calliditas Therapeutics AB - ADR

Calliditas Therapeutics AB (publ) (CALT) Q4 2023 Earnings Call Transcript

Calliditas Therapeutics stock jumps as kidney treatment gets FDA approval

Calliditas Therapeutics: Undervalued Rare Disease Commercial Stage Biotech (Maintaining Buy)

Calliditas Therapeutics AB Sponsored ADR (CALT) Surges 16.1%: Is This an Indication of Further Gains?

Why Shares of Calliditas Therapeutics Are Rising Thursday

Calliditas: Q2 Earnings De-Risk This Biotech Play, 2024 Expected To Be Inflection Point

Trade With A Regulated Broker